Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experienceSophie Park, François Dreyfus, Beatrice Mahé et al.|Blood|2007Cited by 332
A Controlled Study of Recombinant Human Granulocyte Colony-Stimulating Factor in Elderly Patients after Treatment for Acute Myelogenous LeukemiaHervé Dombret, Laurent Degos, Claude Chastang et al.|New England Journal of Medicine|1995Cited by 313
Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experienceLionel Adès, Agnès Guerci, Emmanuel Raffoux et al.|Blood|2009Cited by 251
Is Cytarabine Useful in the Treatment of Acute Promyelocytic Leukemia? Results of a Randomized Trial From the European Acute Promyelocytic Leukemia GroupLionel Adès, Pierre Fenaux, Sylvie Chevret et al.|Journal of Clinical Oncology|2006Cited by 166
Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA resultsLionel Adès, Pierre Fenaux, Miguel Á. Sanz et al.|Blood|2007Cited by 157